Biotechnology company RubrYc Therapeutics, Inc., founded in 2017, has developed a proprietary machine learning-driven solution for the discovery ... optimized antibody–drug conjugates, to ...

Nature Reviews Drug Discovery integrates academia and industry, providing broad, expert coverage of the whole drug discovery and development arena – from disease mechanisms, novel therapeutic ...

Traditionally, researchers obtained such antibodies from rodents using the technique pioneered by Nobel Prize-winners Georges Köhler and César Milstein in the mid-1970s (Nature, 256:495-97, 1975). In ...

Bio-Rad is at the forefront of antibody development, leveraging cutting-edge technologies and expertise to address critical challenges in the field. Bio-Rad’s antibody services including HuCAL TM ...

In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibody discovery and development.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the Pioneer Antibody Discovery Platform, a new ...